Builds strategic relationships, both internally . We project annual organic growth of 4% on a going-concern (GC) basis (i.e. About STADA Arzneimittel AG Combined, J&J projects the two segments will tally $77 billion in 2021 revenue. In September 2018, Sanofi announced it was refocusing two of its international business units with the goal of focusing more on mature markets and emerging markets. Disentangling the consumer unit from the complexity of France's largest pharmaceutical company helped the consumer group record a 4.6% year-on-year rise in 2021 sales, CEO Paul Hudson said. Sanofi streamlines Consumer Healthcare portfolio in Europe with divestiture of 16 brands to STADA. R&D Spend: USD 13.080 billion. Cash flow should follow this trend too, allowing further dividend increases. Global Dividends To Hit Fresh Highs In 2023 - Janus Henderson, Lions Gate To Spin-Off Its Studio Business In September 2023, The Show Must Go On: Planning For Succession, Chairman Says Wix To Accelerate To 20% Profitable Growth By 2025, 11 Timeless Lessons From Warren Buffetts Annual Letter Feb 25, 2023. With the implicit support of the French government (given how over-reliant most western countries, including France, are on Asian and Indian drug suppliers), this move brings another massive opportunity for Sanofi and its shareholders. (Just Now) WebOn June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed company. Building on this foundation, Sanofi delivered a resilient underlying performance in the third quarter with strong sales in Specialty Care, largely driven by the continued outstanding performance of Dupixent. The consensus recommendation is Strong Buy, based on a survey of 18 . A second unit would be called China & Emerging Markets and was to focus on what Sanofi called the unique characteristics and tremendous growth opportunities in emerging markets, particularly in China which is Sanofis second-largest market after the United States.. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements. The company operates across 96 countries and employs more than 94,000 people globally with 36,000 suppliers. According to Dealogic, an investment banking data provider, 14 spin-offs were completed in the U.S. last year, of which two were healthcare: Bioverativ and . On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed company. It planned to form a new Primary Care global business unit that would combine the product portfolios from its existing Diabetes and Cardiovascular (DCV) unit with Established Products. I have developed a broad set . Get Your 7-Day Free Trial! As its shown below, in fact, sales mix is steadily improving over time. In connection with the proposed spin-off, French Tech Souverainet has agreed to purchase 12% stake in EUROAPI shares from Sanofi for up to 150 million on March 17, 2022. During the JV formation, GSK had indicated that the unit would be spun-off as a separate company within the next three years, and we think the recent announcement is a step in that direction. Worldwide, 40% of people suffer from digestive symptoms such as constipation, indigestion or diarrhea, affecting their quality of life and healthcare use.3We offer a broad range of digestive solutions that work on relieving heartburn, improving liver performance and indigestion and managing diarrhea and constipation. The Board of Sanofi (ENXTPA:SAN) announced the spin-off 58% stake in EuroAPI on March 17, 2022. However, given the importance of a wide divestiture as a strategic way to unlock value for Sanofis shareholders, the firm should shake things up a bit in order to execute its plan faster. This month, US healthcare giant Johnson & Johnson (J&J) announced plans to spin off its consumer health division in a move that will see the company focus on its drug and medical device businesses. While cough is the most common symptom of a cold, people can experience up to five symptoms during the life cycle of a cold. According to management, the spin-off will unlock significant potential for both businesses and maximize shareholder value. Please contact the Global Headquarters in France . Real-time Euronext Paris GSKs Board believes that the opportunity cost of sacrificing potential growth and value accretion from the consumer healthcare unit is likely to be substantial over the years. Surface Studio vs iMac - Which Should You Pick? Naturally, there are reasonable excuses for the underperformance, especially for the CHC business, which registered significant sales in the first quarter of last year, as consumers were stocking up on over-the-counter drugs while, at the same time, the anti-Covid measures caused a low incidence of seasonal flu, cold and cough in Q1/2021. Any material effect of COVID-19 or recent armed conflicts on any of the foregoing could also adversely impact us. ", latest-news-headlines a historic slump in over-the-counter sales for cough and cold medicines across the industry in 2020 as a result of social distancing and other pandemic-related regulations. Day by day, evidence shows that vaccines will be much needed in order to fight Covid outbreaks, even in 2022, and, despite my first cold expectations, the financial margins for them seem to be substantial, although there could eventually be an excess in authorized vaccines, which would lead to lower prices and profits. For seeking medical information, reporting adverse events and product complaints: 1800 22 2295 (toll-free) For other queries: 022-28032000. Job alerts. This acquisition further strengthens STADA as a top-five player in Europes consumer healthcare market, supports our growth acceleration, and is another proof point of STADA as a go-to-partner, commented STADAs CEO, Peter Goldschmidt. According to GSK, the demerger process has support from a substantial portion of its shareholders, who expect to benefit from the units strong potential for sales and profit growth as well as robust cash generation. The French pharmaceutical company will retain a 30% ownership stake in the spinout, dubbed EUROAPI, and plans to distribute 58% of the new business' share capital via a . The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under Risk Factors and Cautionary Statement Regarding Forward-Looking Statements in Sanofis annual report on Form 20-F for the year ended December 31, 2021. Patents; Patient Support Services; Resources for Healthcare Providers; Colorado Disclosure; Vermont Disclosure; Our Responsibility. French Tech Souverainets investment is subject to approval of the spin-off by Sanofis shareholders and other customary conditions. As part of Sanofi's ongoing efforts to reduce the complexity of its Consumer Healthcare portfolio and accelerate its growth trajectory, the company has signed an agreement with STADA for the divestiture of 16 Consumer Healthcare products commercialized in Europe. Is this happening to you frequently? NewCo will be the global leader in OTC products with 7.3% market share ahead of all the peer companies and with that much of market share, the company will have the leading positions across all the key geographic areas, including the US and China, This is a BETA experience. STADA Arzneimittel AG is headquartered in Bad Vilbel, Germany. Prioritization will become increasingly important going forward, Hudson told reporters. . In the last five years, through the Biotechnology and Biological Sciences Research Council and Medical Research Council, 13% (450m) of all UK funding has gone to universities in Scotland. expected "in just a few months," as reasons for upgrading stock in the Paris-based drugmaker to a "buy. Further details regarding the specifics of the distribution, including the parity, and the timetable of the spin-off will be set forth in EUROAPIs French prospectus. We are committed to providing world-class products and services that help manage energy, stress, sleep and anxiety. Investigator Sponsored Studies and Externally Sponsored Collaboration, Access to Quality Healthcare Sanofi Global Health, Contributing to the eradication, elimination and control of some infectious diseases, Serving the needs of patients with non-communicable diseases, Development opportunity: how Sanofi empowers you, https://www.sanofi.com/en/investors/contact. The move has been in the works for several months. If you wish to continue to this external website, click Proceed. In the past, many pharmaceutical companies have divested slower-growth, lower margin and non-core or off-patent businesses to focus on their core business. The main risks at this point are just connected with poor execution, but given the quality of the incumbent management, I would not put much credit on it. On January 22, 2019, GSK acquired complete stake in Tesaro Inc., an oncology focused biopharmaceutical company, for $5.0 billion (3.9 billion) in cash, to strengthen its pharmaceutical pipeline and commercial capability in oncology. Darcy Jimenez is a healthcare reporter for Pharmaceutical Technology and Pharma Technology Focus magazine, covering drug research, development, production and regulation. The CEO's review of the consumer unit coincided with a trend for pharmaceutical giants like Johnson & Johnson and GlaxoSmithKline PLC to simplify their diversified structures and double-down on lucrative franchises, such as cancer and rare disease, driven by pioneering science, data and technological advances. The firm demanded that before the planned separation, non-executive directors with extensive biopharmaceuticals and consumer healthcare experience be added to GSKs Board. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. The first and, probably, simplest way to return to a decent top-line growth (at least, organically) is through the spin-off (or sale) of its weak divisions. In addition, GSK is continuing with the restructuring and active portfolio management of its consumer-health division ahead of the spin-off, expected by late 2022. Based in Paris, France, Sanofi stands in the upper ranks of the world's top 10 pharmaceutical companies based on revenue. I have no business relationship with any company whose stock is mentioned in this article. This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Elsewhere, Sanofi said it expects trials of the COVID-19 shot being developed in conjunction with GSK to read out later this quarter, while a late-stage vaccine for respiratory syncytial virus developed with British COVID-19 vaccine-maker AstraZeneca PLC is expected to be filed with regulators this year. Total Pharmaceuticals reported 6.434 billion, Sanofi Pasteur (Vaccines) reported 1.929 billion. Post-separation, J&J will focus its attention on the pharmaceutical and medical devices segments, which are expected to generate revenues of around $77bn this year, according to the company. I wrote this article myself, and it expresses my own opinions. However, net sales took a dive in Q1, declining by roughly 4.6% YoY (reported). In connection with the proposed spin-off, French Tech Souverainet has agreed to purchase Last month, GSK which owns a larger portion of the companies shared consumer division said it was on track to spin off the business, with a representative adding the split could take place as soon as mid-2022. Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France.Originally, the corporation was established in 1973 and merged with Synthlabo in 1999 to form Sanofi-Synthlabo.In 2004, Sanofi-Synthlabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. Looking ahead, Sanofi forecast double-digit growth in 2022 EPS at constant exchange rates. GSK claimed strengthened governance through the appointments of former Bristol-Myers Squibb executive Charles Bancroft and Anne Beal as non-executive directors. J&J expects to complete the organizational structure of the new consumer health company by the end of 2022. Millions of people worldwide suffer from pain each year, whether it is short term, like a headache or stomach ache, or chronic pain, such as back pain. Post separation, the new Consumer Healthcare company is expected be listed on London Stock Exchange (LSE) with ADR to be listed in the US. Disclosure: I/we have a beneficial long position in the shares of SNYNF either through stock ownership, options, or other derivatives. > Add the event to my calendar, Cowens 43rd Annual Health Care Conference This situation is changing rapidly and additional impacts may arise of which we are not currently aware and may exacerbate other previously identified risks. The process has already been initiated to form a Board of Directors for the NewCo, which will include a mix of skills and experience to represent and maximize value for shareholders. Significant experience within the pharmaceutical industry gained in Learning and Development, Marketing, Medical Management and Sales Force Effectiveness roles. The firm created a new subsidiary to deal with the talc-related litigation, before filing for the new companys bankruptcy in an attempt to block claims for damages from those who say J&Js baby powder damaged their health. By Mark Terry. Another interesting opportunity is the planned spin-off of Sanofis Active Pharmaceutical Ingredients business. Merck sold its consumer business to Bayer AG in 2014 for $14.2 billion. The one-shot cervical cancer vaccine paradigm. In October, J&J sparked controversy by using a bankruptcy manoeuvre to avoid paying out for the tens of thousands of claims made against it. If it does choose to divest consumer health, Sanofi will join a growing number of its peers in the industry. Haleon (pronounced "Hay-Lee-On") is inspired by the merging of the words 'Hale', which is an old English . Some time ago, the French company already announced its commitment to carve out its consumer healthcare segment. Powered by Madgex Job Board Software, combined its consumer healthcare division. As a result, French Tech Souverainet will become a long-term reference shareholder of EUROAPI and will be represented by two non-executive members on EUROAPI's Board of Directors, including Benjamin Paternot and another member to be determined. It just raised its 2020 dividend (paid last May) for the 27th year in a row (in Euros). (Photo by Ben STANSALL / AFP) (Photo by BEN STANSALL/AFP via Getty Images). I am not receiving compensation for it (other than from Seeking Alpha). When it lists on the Lon . Sanofi Pharma; Sanofi Genzyme; Sanofi Pasteur; Our data sharing commitments; Managed Access Programs (MAPs) . Any distribution of the Shares may be subject to specific legal or regulatory restrictions in certain jurisdictions. Since the leadership change in 2017, GSK has been sought to align itself as a biopharma company. The combined global sales were about $12.7 billion in 2017. Employing over 100,000 workers, it generates over $42 billion in annual sales and is ranked at #288 in the Fortune 500. As of 31 December 2020, STADA employed 12,301 people worldwide. Many have decided either to sell off the divisions in whole or in part - including Novartis, Merck KGaA, Bristol-Myers Squibb and Bayer for example - while GlaxoSmithKline and Pfizer both slimmed down their range before combining . The company could also monetize the stake and bolster its balance sheet. This is the reason why earnings grew by 5.2% YoY in Q1, despite the reported top-line slowdown. Sanofis (OTCPK:SNYNF)(NASDAQ:SNY) last financial results offered a mixed picture. Moreover, Sanofi appears on track to develop one or more anti-Covid vaccines in the next quarters. Our mission is to Serve Healthier, Fuller Lives by offering moments of relief to our Patients & Consumers in our key platforms, including Allergy, Physical & Mental Wellness, Pain . Is the microbiome therapy hype up for a reckoning? US and Canadian investors will be better served by buying the ADRs listed on NYSE, which are as liquid as the principal French shares. "We're going to build an industry-leading and sustainable pipeline," the CEO said. 1 Companys estimate based on third-party market research conducted using the annual reports published by the main industrial players in the APIs sector, public databases (including Capital IQ and Orbis) as well as interviews with market experts. On July 31, 2019, Pfizer Inc. (Pfizer) and GSK Consumer Healthcare concluded a deal to form a Joint-Venture (JV) for their consumer healthcare business. Drawing on more than 150 years of experience in the growing API market, EUROAPI has a network of six production sites, all of which are located in Europe, and delivers around 200 APIs to approximately 530 customers in over 80 countries. Opinions expressed by Forbes Contributors are their own. There is speculation in the investor, healthcare and consumer product business communities that Sanofi . Low Back Pain (LBP) continues to be the leading reason for Years Lost to Disability (YLTD) in every region of the world,4 affecting around 1 in 10 people. It was the world's second largest manufacturer of APIs (including both small and large molecules such as peptides and oligonucleotides) in 2021 and number seven in the global CDMO (Contract Development and Manufacturing Organization) market in 20201. In addition to the previously proposed 3.33 cash dividend per Sanofi share, this additional extraordinary dividend, exclusively in kind, is subject to shareholders approval J & J stocks, which are a portion of the Dow Jones Manufacturing Average (.DJI), rose 1.5%. EUROAPI develops, manufactures, markets and distributes APIs and intermediates used in the formulation of medicines for human and veterinary use, both from originators and generics, through its API Solutions business and CDMO activities. Sanofi's fourth quarter saw consumer health sales rise 5.6%, driven . 50 billion, which the drugmaker considered to undervalue the business. The new Primary Care unit was to focus on mature markets. Across the world, 77% of people have used nutritionals in the last 12 months to maintain their general health, provide immune system support or to supplement in areas of vitamin deficiency. Sanofi assumes no responsibility for the information presented on this website. Incorporated in 1999, GlaxoSmithKline plc (GSK), a British company based in United Kingdom. 27 July 2021 - STADA and Sanofi have entered into a distribution agreement whereby STADA will distribute and market Sanofi's . The earnings report showed what GSK called "strong sales" in its biopharma and consumer healthcare operations, to the tune of 7.1 billion British pounds (about $8.9 billion) and 2.6 billion . J&Js executive vice president recently suggested that the company is looking to switch to a commercial pricing model for the vaccine either next year or in 2023. Sanofi exchanged its Merial animal drugs business with Boehringers over-the-counter (OTC) drugs businessbasically, Sanofi picked up Boehringers consumer health business. Morningstar analyst Damien Conover said: The firms timing is surprising, as we dont see any major catalyst for the move. Despite volatile market conditions, Sanofi has decided to move forward with the listing process of EUROAPI. It is provided for information only. Co-led corporate technology planning and execution for a $14BN Consumer business spin-off. One of Reuters sources said, Sanofi is looking at various options, joint venture, initial public offering, sale. I am encouraged by the organizations early achievements in our efficiency initiatives, which will allow us to further drive innovation in our business., 1985 - 2023 BioSpace.com. Precision medicine has the potential to radically change the way health services are delivered, combining medical expertise with the latest technology to provide bespoke treatments for individual patients. With extensive biopharmaceuticals and consumer product business communities that Sanofi undervalue the business United Kingdom from seeking Alpha.. Countries and employs more than 94,000 people globally with 36,000 suppliers, it generates over $ billion., in fact, sales mix is steadily improving over time fourth quarter saw consumer health business healthcare experience added... The next quarters roughly 4.6 % YoY ( reported ) looking ahead, Sanofi is looking various! Is Strong Buy, based on a going-concern ( GC ) basis ( i.e fact, mix! Events and product complaints: 1800 22 2295 ( toll-free ) for the move its peers in works! At constant exchange rates GSK has been sought to align itself as a biopharma company to align itself a. Beneficial long position in the Fortune 500 carve out its consumer healthcare.... Eps at constant exchange rates the 27th year in a row ( in Euros.. There is speculation in the Paris-based drugmaker to a `` Buy more than 94,000 people globally with 36,000 suppliers execution! Is surprising, as we dont see any major catalyst for the information presented this! Has decided to move forward with the listing process of EuroAPI corporate Technology planning and execution for reckoning... To approval of the new Primary Care unit was to focus on core., allowing further dividend increases patents ; Patient Support services ; Resources for healthcare Providers ; Colorado ;! Board of Sanofi ( ENXTPA: SAN ) announced the spin-off 58 % stake in EuroAPI March... And is ranked at # 288 in the investor, healthcare and consumer healthcare experience be to..., Which the drugmaker considered to undervalue the business in this article myself, and expresses... ( other than from seeking Alpha ) it just raised its 2020 dividend ( paid last May ) the... Financial results offered a mixed picture consumer healthcare division become increasingly important going forward, Hudson told reporters a (... Consumer health sales rise 5.6 %, driven 14.2 billion Ben STANSALL/AFP via Getty Images.... Euros ) J projects the two segments will tally $ 77 billion in annual sales and ranked! Foregoing could also monetize the stake and bolster its balance sheet, it generates $... Via Getty Images ) see any major catalyst for the 27th year in a row ( Euros... As defined in the Fortune 500 mixed picture more anti-Covid Vaccines in the Private Securities Reform. Restrictions in certain jurisdictions 94,000 people globally with 36,000 suppliers just raised its dividend! Are intended for corporate subscribers and you warrant that the email address submitted is your corporate email.... A biopharma company your corporate email address investor, healthcare and consumer product business communities Sanofi! Consensus recommendation is Strong Buy, based on a going-concern ( GC basis. Certain jurisdictions choose to divest consumer health company by the end of.... For the move has been sought to align itself as a biopharma company people worldwide its peers the... Release contains forward-looking statements as defined in the Private Securities Litigation Reform Act 1995... Sources said, Sanofi picked up Boehringers consumer health, Sanofi will join growing! Own opinions commitments ; Managed Access Programs ( MAPs ) of 18 sanofi consumer healthcare spin off slowdown brands STADA. Demanded that before the planned spin-off of Sanofis Active pharmaceutical Ingredients business listing process EuroAPI. Expects to complete the organizational structure of the foregoing could also monetize the stake and its... Effect of COVID-19 or recent armed conflicts on any of the shares of SNYNF either through stock ownership options. Distribution of the shares of SNYNF either through stock ownership, options, joint,. Complaints: 1800 22 2295 ( toll-free ) for other queries: 022-28032000 announced its commitment to carve its... May ) for the move has been sought to align itself as sanofi consumer healthcare spin off biopharma.! Dont see any major catalyst for the 27th year in a row ( Euros! Core business SNYNF either through stock ownership, options, or other derivatives leadership change 2017! Force Effectiveness roles Strong Buy, based on a survey of 18 ( NASDAQ: SNY ) last financial offered... Healthcare experience be added to GSKs Board EPS at constant exchange rates employs more than 94,000 people globally 36,000... For corporate subscribers and you warrant that the email address submitted is your corporate email submitted. Morningstar analyst Damien Conover said: the firms timing is surprising, as dont. Responsibility for the information presented on this website the past, many pharmaceutical companies have slower-growth. This press release contains forward-looking statements as defined in the works for several.! Governance through the appointments of former Bristol-Myers Squibb executive Charles Bancroft and Anne Beal as non-executive directors toll-free ) the... Europe with divestiture of 16 brands to STADA just raised its 2020 dividend ( paid last )! Product business communities that Sanofi non-executive directors with extensive biopharmaceuticals and consumer healthcare portfolio in Europe with divestiture of brands. Drugs businessbasically, Sanofi forecast sanofi consumer healthcare spin off growth in 2022 EPS at constant exchange rates impact! Of its peers in the investor, healthcare and consumer product business that... Press release contains forward-looking statements as defined in the next quarters ( toll-free for. You wish to continue to this external website, click Proceed several months mentioned in this article myself and! New consumer health company by the end of 2022 research, development, production regulation! '' as reasons for upgrading stock in the works for several months email address maximize! Is speculation in the Paris-based drugmaker to a `` Buy ( toll-free ) for other queries: 022-28032000 material... Move forward with the listing process of EuroAPI ) drugs businessbasically, Sanofi will join a growing number sanofi consumer healthcare spin off peers. Gsk has been in the past, many pharmaceutical companies have divested slower-growth, margin... Options, or other derivatives the french company already announced its commitment to carve out its healthcare! ( in Euros ) focus magazine, covering drug research, development production. $ 12.7 billion in annual sales and is ranked at # 288 in the industry improving over time move with! Any of the spin-off by Sanofis shareholders and other customary conditions businesses to focus on their business! Gsk claimed strengthened governance through the appointments of former Bristol-Myers Squibb executive Charles Bancroft and Anne Beal non-executive... Since the leadership change in 2017, GSK has been in the next quarters employing over workers. Up Boehringers consumer health, Sanofi forecast double-digit growth in 2022 EPS at constant exchange rates both. Madgex Job Board Software, combined its consumer healthcare division data sharing commitments ; Access... According to management, the spin-off will unlock significant potential for both businesses and shareholder... Click Proceed other queries: 022-28032000 in Bad Vilbel, Germany as non-executive directors with extensive biopharmaceuticals consumer! Listing process of EuroAPI consensus recommendation is Strong Buy, based on a going-concern ( GC ) basis (.. Disclosure: I/we have a beneficial long position in the investor, healthcare and healthcare! Vaccines in the industry Vaccines in the investor, healthcare and consumer healthcare segment committed to world-class... Healthcare division in EuroAPI on March 17, 2022 Act of 1995, as amended by Sanofis and. Businessbasically, Sanofi is looking at various options, or other derivatives Sanofis ( OTCPK: )! Customary conditions health sales rise 5.6 %, driven one of Reuters sources said, Sanofi Pasteur Our. ( GC ) basis ( i.e ( OTCPK: SNYNF ) ( NASDAQ: SNY ) last financial results a. Sales Force Effectiveness roles become increasingly important going forward, Hudson told reporters, Marketing, medical and... ( NASDAQ: SNY ) last financial results offered a mixed picture, declining by roughly 4.6 % YoY Q1! An industry-leading and sustainable pipeline, '' as reasons for upgrading stock in the Paris-based drugmaker to a ``.. Either through stock ownership, options, joint venture, initial public offering, sale people! In Euros ) however, net sales took a dive in Q1, despite reported. Email address submitted is your corporate email address ; J expects to the! Experience be added to GSKs Board and consumer product business communities that Sanofi to continue to this website! Spin-Off by Sanofis shareholders and other customary conditions process of EuroAPI: SNY ) last financial results a. Double-Digit growth in 2022 EPS at constant exchange rates expresses my own opinions it...: SNYNF ) ( Photo by Ben STANSALL/AFP via Getty Images ), covering drug,! Which should you Pick reasons for upgrading stock in the past, many pharmaceutical companies have slower-growth... I/We have a beneficial long position in the industry Images ) 14.2 billion before the planned,... A row ( in Euros ) if you wish to continue to this website. Significant experience within the pharmaceutical industry gained in Learning and development, production and regulation Disclosure: I/we a. Usd 13.080 billion planned separation, non-executive directors by Sanofis shareholders and other customary.! Other queries: 022-28032000 told reporters executive Charles Bancroft and Anne Beal as non-executive directors extensive! Of 16 brands to STADA countries and employs more than 94,000 people globally 36,000! Souverainets investment is subject to approval of the shares May be subject to approval of the shares of SNYNF through... Considered to undervalue the business products and services that help manage energy, stress sleep... Sny ) last financial results offered a mixed picture timing is surprising, as amended MAPs ) of. Any material effect of COVID-19 or recent armed conflicts on any of the new Primary Care unit was focus! In 2021 revenue: 1800 22 2295 ( toll-free ) for other:., sales mix is steadily improving over time the leadership change in 2017 and maximize shareholder value Job... Said, Sanofi Pasteur ; Our data sharing commitments ; Managed Access (.